Furthermore, positive staining for advanced glycation end-products (AGE), a diabetes-specific inflammatory and oxidant activator [35], was similar to that of vascular inflammatory mediators and SREBP-1 within lesions (Fig. 7A–D). This evidence concerns the gene SREBF1 and diabetes mellitus.